期刊
PHARMACEUTICAL RESEARCH
卷 28, 期 11, 页码 2871-2882出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-011-0516-4
关键词
DNA import; mitochondrial disease; mitochondrial plasmid; organelle transfection; protein phosphorylation
资金
- French Centre National de la Recherche Scientifique (CNRS) [UPR2357]
- Universite de Strasbourg (UdS)
- Agence Nationale de la Recherche [ANR-06-MRAR-037-02]
- Welcome Trust
- Russian Academy of Sciences (RAS)
- Russian Foundation for Basic Research (RFBR)
Mitochondria are competent for DNA uptake in vitro, a mechanism which may support delivery of therapeutic DNA to complement organelle DNA mutations. We document here key aspects of the DNA import process, so as to further lay the ground for mitochondrial transfection in intact cells. We developed DNA import assays with isolated mitochondria from different organisms, using DNA substrates of various sequences and sizes. Further import experiments investigated the possible role of ATP and protein phosphorylation in the uptake process. The fate of adenine nucleotides and the formation of phosphorylated proteins were analyzed. We demonstrate that the efficiency of mitochondrial uptake depends on the sequence of the DNA to be translocated. The process becomes sequence-selective for large DNA substrates. Assays run with a natural mitochondrial plasmid identified sequence elements which promote organellar uptake. ATP enhances DNA import and allows tight integration of the exogenous DNA into mitochondrial nucleoids. ATP hydrolysis has to occur during the DNA uptake process and might trigger phosphorylation of co-factors. Our data contribute critical information to optimize DNA delivery into mitochondria and open the prospect of targeting whole mitochondrial genomes or complex constructs into mammalian organelles in vitro and in vivo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据